<DOC>
	<DOCNO>NCT00874237</DOCNO>
	<brief_summary>The purpose present Phase 1 study ass cardiac safety Staccato Loxapine administer healthy volunteer 3 period crossover study .</brief_summary>
	<brief_title>Staccato Loxapine Thorough QT/QTc</brief_title>
	<detailed_description />
	<mesh_term>Loxapine</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Subjects good general health agree use medically acceptable effective birth control method throughout study . Subjects take prescription nonprescription medication within 5 day treatment , Subjects acute illness within last 5 day treatment , Subjects smoker , OR Subjects ECG abnormality baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Staccato loxapine</keyword>
	<keyword>QTc</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>